![Michael Mendelsohn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Mendelsohn
Directeur/Bestuurslid bij
FOGHORN THERAPEUTICS INC.
Vermogen: - $ op 30-06-2026
Profiel
Dr. Michael E. Mendelsohn, MD, is een Onafhankelijk Bestuurder bij Cyclerion Therapeutics, Inc., een Onafhankelijk Bestuurder bij Foghorn Therapeutics, Inc., een Voorzitter bij Cardurion Pharmaceuticals LLC, een Chief Medical & Scientific Officer bij Takeda Pharmaceutical Co., Ltd. en een President bij Mendelsohn Consulting Group LLC. Hij zit in de Raad van Bestuur van Cyclerion Therapeutics, Inc. en Foghorn Therapeutics, Inc. Dr. Mendelsohn was voorheen werkzaam als President & Chief Scientific Officer bij Ironwood Pharmaceuticals, Inc., Venture Partner bij SV Life Sciences Managers LLP, Onafhankelijk Bestuurder bij Regado Biosciences, Inc., Senior VP & Global Head-Cardiovascular Research bij Merck Research Laboratories Massachusetts LLC, Executive Director-MCRI bij Tufts Medical Center, Inc., en Chief Scientific Officer bij Tufts University School of Medicine. Hij behaalde zijn doctoraal aan het Amherst College en zijn doctoraal aan de Harvard Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van Michael Mendelsohn
| Bedrijven | Functie | Begin |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur/Bestuurslid | 01-04-2017 |
Cardurion Pharmaceuticals, Inc.
 Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Oprichter | 01-05-2016 |
Mendelsohn Consulting Group LLC | Oprichter | 01-09-2013 |
Eerdere bekende functies van Michael Mendelsohn
| Bedrijven | Functie | Einde |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2018 |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Corporate Officer/Principal | 01-07-2017 |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Directeur/Bestuurslid | 01-05-2015 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 01-11-2013 |
Tufts Medical Center, Inc.
 Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Oprichter | 01-05-2010 |
Opleiding van Michael Mendelsohn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
65
Eerstegraads connecties
14
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 14 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Finance |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Cardurion Pharmaceuticals, Inc.
Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Health Technology |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Mendelsohn Consulting Group LLC |
